|
InBody is a medical device manufacturer specializing in body composition analysis technology. Founded in 1996, the company develops and produces professional and home-use body composition analyzers, automatic blood pressure monitors, height meters, and related software. Its product portfolio includes the InBodyDial H30, InBodyDial H40, and InBodyFit for the consumer market, alongside professional-grade devices used in clinical and sports settings. InBody operates through a global network of subsidiaries and distributors, with key markets in the United States, Japan, China, and Europe. The company serves customers including hospitals, fitness centers, obesity clinics, military units, schools, and individual consumers. It maintains production facilities in South Korea and China, and holds regulatory certifications from the US FDA, European CE, and Japanese JPAL. InBody also leverages its data assets to develop AI-driven healthcare solutions and software services. Summarised from the company's own disclosures, fiscal year ended Mar 2026 |
Industry Medical Devices | Homepage inbody.com |
| Sector Healthcare | IR page — | |
|
Tags
body composition analysis, bioelectrical impedance analysis, blood pressure monitoring, home healthcare, sports medicine, obesity management, preventive medicine, digital health, ai healthcare, InBody, InBodyDial H30, InBodyDial H40, InBodyFit, BWA, Biospace China Co. Ltd., InBody China Medical Technology Co. Ltd., Inbody Europe B.V., InBody UK LIMITED, InBody Asia, InBody India, InBody Oceania, InBody Asia Pte.
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | — |
| Market cap (USD) | — |
| P/E | — |
| PEG | — |
| P/BV | — |
| P/S | — |
| P/OCF | — |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 10.4% |
| ROI | 9.6% |
| ROIC | 9.0% |
| Profit margin | 13.1% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | -3.2% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | — |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | — |
| Quality score | 54.5% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 233.948B | 204.465B | 170.351B | 160.004B | 137.837B | 107.122B | 117.059B | 99.635B | 93.254B | 79.848B | 68.949B | 48.94B | 36.787B |
| Net profit | 30.633B | 33.143B | 36.723B | 33.816B | 34.033B | 17.518B | 20.428B | 19.671B | 19.322B | 16.987B | 17.311B | 8.879B | 6.194B |
| Free cash flow | 28.865B | 22.315B | 31.235B | 25.039B | 19.059B | 26.814B | 21.134B | -23.159B | 13.264B | 10.607B | — | 8.792B | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (KRW) | 11B | 12.3B | 12B | 10.6B | 8.76B | 17.3B | 18.1B | 17.4B | 25.2B | 31.6B |
| ↳ YoY growth | +10.0% | +12.0% | -2.2% | -12.1% | -17.0% | +97.9% | +4.4% | -3.7% | +44.5% | +25.5% |
| ↳ 5y CAGR | +24.0% | +20.4% | -2.5% | +9.6% | +8.1% | +7.7% | +19.0% | +29.3% | ||
| Borrowings, current (KRW) | — | — | — | — | — | — | — | 0.00 | 0.00 | 559M |
| Lease liabilities (KRW) | — | — | — | 4.81B | 4.79B | 3.87B | 6.4B | 6.08B | 8.42B | 9.78B |
| Cash and deposits (KRW) | 10.3B | 11.2B | 9.63B | 14.4B | 17B | 18.6B | 21.6B | 22.3B | 31B | 52.4B |
| Intangible assets (KRW) | 1.69B | 1.51B | 1.14B | 758M | 727M | 1.32B | 1.68B | 1.22B | 2.03B | 1.85B |
| Right-of-use assets (KRW) | — | 0.00 | 0.00 | 4.63B | 4.7B | 3.77B | 6.31B | 5.91B | 7.94B | 9.75B |
| Net debt (borrowings + leases - cash) (KRW) | — | — | — | — | — | — | — | -16.2B | -22.6B | -42B |
| Cash flow detail | ||||||||||
| Operating cash flow (KRW) | 18.2B | 18.6B | 17.7B | 24.2B | 28.5B | 30.4B | 30.4B | 38.7B | 28.6B | 35.8B |
| Purchases of property, plant and equipment (KRW) | -7.63B | -5.31B | -40.9B | -3.07B | -1.69B | -11.3B | -5.38B | -7.45B | -6.26B | -6.91B |
| Purchases of intangible assets (KRW) | -774M | -269M | -74.8M | -198M | -233M | -545M | -637M | -192M | -1.29B | -509M |
| Dividends paid (cash effect) (KRW) | -1.09B | -1.36B | -1.62B | -1.62B | -1.86B | -1.82B | -2.61B | -3.91B | -4.56B | -5.04B |
| Share buybacks (cash effect) (KRW) | — | -2.85B | -258M | -3.74B | -5B | — | — | 0.00 | -7.47B | -12.5B |
| Interest paid (cash effect) (KRW) | — | — | -122M | -3.15M | -126M | -104M | -122M | -334M | -388M | -497M |
| Income taxes paid (cash effect) (KRW) | -5.18B | -3.79B | -4.02B | -8.39B | -5.58B | -4.61B | -8.07B | -11.9B | -10B | -10.1B |
| Free cash flow (OCF - PPE - intangibles) (KRW) | 9.83B | 13B | -23.2B | 20.9B | 26.6B | 18.5B | 24.4B | 31B | 21B | 28.4B |
| Income detail | ||||||||||
| Total comprehensive income (KRW) | 17.1B | 18.4B | 19.7B | 20.7B | 17.2B | 35.5B | 34.1B | 37.2B | 35.8B | 30.6B |
| Comprehensive income to owners (KRW) | 17.1B | 18.4B | 19.8B | 20.7B | 17.2B | 35.5B | 34.1B | 37.4B | 36.2B | 31.3B |
| Reported | Apr 2, 2018 | Mar 30, 2020 | Mar 30, 2020 | Aug 26, 2020 | Mar 16, 2021 | Mar 18, 2024 | Mar 18, 2024 | Mar 18, 2026 | Mar 18, 2026 | Mar 18, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpDisclosures filed with DART (material events and exchange disclosures), newest first, headlines as filed in Korean. The link opens the filing on DART.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding InBody
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.